首页> Multiple sclerosis (Houndmills, Basingstoke, England)> Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.

Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shannon,McCurdy

第一单位： Octave Bioscience Inc., Menlo Park, CA, USA.

作者： Shannon,McCurdy ^[1] ; Elisa,Sheng ^[1] ; Kian,Jalaleddini ^[1] ; Gargi,Datta ^[1] ; Tamara,Shabi ^[2] ; Annalise E,Miner ^[2] ; Alexander,Hari ^[1] ; Srushti,Tiwari ^[1] ; Wayne,Hu ^[1] ; Franklin,Faust ^[1] ; Kelly,Leyden ^[1] ; Sarah,Eagleman ^[1] ; David M,Brazel ^[1] ; Terrie,Livingston ^[1] ; Ferhan,Qureshi ^[1] ; Jennifer S,Graves ^[2]

作者单位： Octave Bioscience Inc., Menlo Park, CA, USA. ^[1] Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. ^[2]

关键词 Relapsing-remitting multiple sclerosis disease activity glial fibrillary acidic protein minimum detectable change neurofilament light chain reliability serum biomarkers